Acton Pharmaceuticals

Marlborough, United States Founded: 2008 • Age: 18 yrs Acquired By Meda
Generic drugs for respiratory disorders are manufactured and commercialized.
Request Access

About Acton Pharmaceuticals

Acton Pharmaceuticals is a company based in Marlborough (United States) founded in 2008 was acquired by Meda in August 2013.. Acton Pharmaceuticals has raised $36.7 million across 4 funding rounds from investors including Sequoia Capital and Mylan.

  • Headquarter Marlborough, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $36.7 M (USD)

    in 4 rounds

  • Latest Funding Round
    $7 M (USD), Series B

    May 13, 2013

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Meda

    (Aug 30, 2013)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Acton Pharmaceuticals

Acton Pharmaceuticals has successfully raised a total of $36.7M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $7 million completed in May 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Series B — $7.0M
  • First Round

    (14 Dec 2009)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2013 Amount Series B - Acton Pharmaceuticals Valuation

investors

Sep, 2010 Amount Series A - Acton Pharmaceuticals Valuation

investors

Jan, 2010 Amount Series A - Acton Pharmaceuticals Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Acton Pharmaceuticals

Acton Pharmaceuticals has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Sequoia Capital and Mylan. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Sequoia Capital is engaged in venture capital investments.
Founded Year Domain Location
Mylan, part of Viatris, is focused on healthcare solutions.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Acton Pharmaceuticals

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Acton Pharmaceuticals

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Acton Pharmaceuticals Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Acton Pharmaceuticals

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Acton Pharmaceuticals

Frequently Asked Questions about Acton Pharmaceuticals

When was Acton Pharmaceuticals founded?

Acton Pharmaceuticals was founded in 2008 and raised its 1st funding round 1 year after it was founded.

Where is Acton Pharmaceuticals located?

Acton Pharmaceuticals is headquartered in Marlborough, United States. It is registered at Marlborough, Massachusetts, United States.

Is Acton Pharmaceuticals a funded company?

Acton Pharmaceuticals is a funded company, having raised a total of $36.7M across 4 funding rounds to date. The company's 1st funding round was a Series A of $15M, raised on Dec 14, 2009.

What does Acton Pharmaceuticals do?

Acton Pharmaceuticals was established in 2008 in Marlborough, United States, within the pharmaceuticals sector. Focus is placed on developing and commercializing products for respiratory conditions, including generic drugs. Operations center on treatment solutions for such disorders. Acquisition by Meda Pharmaceuticals occurred on August 30, 2013, integrating its activities into the larger entity.

Who are Acton Pharmaceuticals's investors?

Acton Pharmaceuticals has 2 investors. Key investors include Sequoia Capital, and Mylan.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available